2C-B-FLY Stats & Data

2C-B-FLY’s oral onset can be slow and variable (20–180+ minutes), so redosing early carries a real overshoot risk; wait at least 3 hours before considering any additional dose. Mislabeling events in 2009 involved Bromo-DragonFLY being sold as 2C-B-FLY; the former is far more potent, longer-lasting, and notably more vasoconstrictive—use reagent tests as a preliminary screen only and prefer GC/MS drug checking when feasible; treat unknown batches with allergy tests (≤1 mg) and conservative titration. Insufflation is commonly reported as extremely painful for 2C-x and specifically for 2C-B-FLY; it tends to shorten duration and roughen the come-up—oral is generally preferred for predictability. As with phenethylamine psychedelics, expect transient increases in heart rate and blood pressure; those with cardiovascular, seizure, or bipolar disorders should avoid or consult a clinician. Salt form affects mass: most references cite the HCl or HBr salts; HBr typically requires roughly 10–20% more mass than HCl for equivalent base—always calculate by salt and weigh accurately. Because of the slow come-up and moderate length, plan set/setting, hydration, and recovery time; avoid combining with stimulants, tramadol, or MAOIs. If effects escalate well past 12 hours with pronounced cold/numb extremities and severe vasoconstriction, suspect misidentification (e.g., Bromo-DragonFLY) and seek medical care; do not redose or take vasoconstrictors. As with all psychedelics, cross-tolerance with other 5-HT2A agonists occurs for several days; spacing experiences by 2+ weeks helps restore baseline sensitivity and reduces compulsive redosing pressure.